Clinical Research Directory
Browse clinical research sites, groups, and studies.
Botulinum Toxin Injection Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
Sponsor: Eye & ENT Hospital of Fudan University
Summary
This is a single-center, prospective, randomized controlled trial evaluating type A botulinum toxin injection and prism therapy for the treatment of small-angle acute acquired concomitant esotropia. Specific Aim 1 (Primary): To compare the reduction of deviation angle and improvement of diplopia symptoms between botulinum toxin injection and prism therapy for the treatment of small-angle acute acquired concomitant esotropia. Specific Aim 2 (Secondary): To compare the improvement of visual functions between botulinum toxin injection and prism therapy for the treatment of small-angle acute acquired concomitant esotropia.
Official title: A Single-center, Prospective, Randomized Controlled Trial Evaluating Type a Botulinum Toxin Injection and Prism Therapy for the Treatment of Acute Acquired Concomitant Esotropia
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-12-10
Completion Date
2026-12-10
Last Updated
2024-12-05
Healthy Volunteers
No
Conditions
Interventions
prism treatment group
wearing prism glasses
botulinum toxin group
botulinum toxin injection
Locations (1)
Eye & ENT Hospital of Fudan University
Shanghai, China, China